摘要：

The invention provides compounds having Formula Ia, or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 4 and Y are as defined in the specification; as well as pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).

展开